Trials / Completed
CompletedNCT06683768
A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension
Safety of Hypertension Medication Therapy in Patient With Naive Hypertension: a Real-world Study in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40,563 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a non-interventional, secondary use of data, retrospective, cohort study. The data extracted in this study was used as secondary use of collected patient information in the database, Japan Medical Data Survey (JAMDAS), owned by M3 Inc. (Tokyo, Japan). JAMDAS is a database that aggregates medical information and is constructed mainly from electronic medical record information of medical institutions, allowing real-time extraction of information entered in medical records, such as prescription status including drug switching and continuation, laboratory values, clinical evaluation scores, and comorbidities etc.
Conditions
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2023-11-08
- Completion
- 2023-11-08
- First posted
- 2024-11-12
- Last updated
- 2024-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06683768. Inclusion in this directory is not an endorsement.